NL-OMON48036
Completed
Not Applicable
Biomarkers in Atopic Dermatitis and Psoriasis The Netherlands - BIOMAP
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atopic dermatitis
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 110
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with atopic dermatitis participating in the TREAT NL registry.
- •Patients can be part of the TREAT NL registry if they have atopic dermatitis
- •AND start with a systemic immunomodulating treatment or phototherapy in the
- •context op standard patient care
Exclusion Criteria
- •No participation in the TREAT NL registry, patients not recieving systemic
- •immunomodulating treatment or phototherapy as treatment for their eczema
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)Dermatitis AtopicNCT03849716Sanofi266
Active, not recruiting
Not Applicable
AMBITIOUSAtopic Dermatitis Biomarker Identification Trial in Omalizumab UsageSingle- arm trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitis - AMBITIOUSAMBITIOUS is a trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitisAtopische Dermatitis is a common inflammatory skin disease showing chronically relapsing eczema and high association with elevated serum IgE levels.MedDRA version: 14.0Level: LLTClassification code 10029264Term: Neurodermatitis aggravatedSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2010-018559-84-DEMedizinische Fakultät der technischen Universität Muenchen20
Recruiting
Not Applicable
BIOMAD NL study<p>Atopic dermatitis, atopic eczema</p>NL-OMON21253Amsterdam UMC, Academic Medical Center110
Terminated
Phase 4
A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS WithdrawalDermatitis, AtopicNCT02317276University of California, San Francisco11
Unknown
Not Applicable
Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of PsoriasisPsoriasisNCT00372580National Taiwan University Hospital110